IL-12 is a proinflammatory cytokine with strong tumor inhibitory activity that not only stimulates T cells to secrete IFN-γ to enhance the cytotoxicity of CAR-T cells, but also generates resistance to Treg cells effects, reshaping the TME in an IFN-γ-dependent manner (48). The gene discussed is IFNG; the disease is neoplasm.